Professional Documents
Culture Documents
1. Myelosuppression (dose-limiting)
• Anemia
• Neutropenia
• Thrombocytopenia
• Pancytopenia
2. Nausea and Vomiting
3. Alopecia
4. Sterility – Gonadal damage
5. Mucositis – oral ulcers
6. Intestinal denudation – Diarrhea
7. Neurotoxicity
• Altered mental status
• Coma
• Seizures
• Ataxia
8. Pulmonary fibrosis
9. Veno-occlusive disease of liver (VOD)
10. Secondary malignancies (mostly AML)
Antimetabolites
• Cladribine (DOC)
• Interferon – α
• Pentostatin
• Vemurafenib (due to presence of V600E BRAF mutations)
Metabolism of irinotecan:
Irinotecan
↓ Carboxylesterases in liver
Active metabolite (SN-38)
↓ UGT1A1
Inactivate SN-38 glucuronide
Flagellate dermatitis:
Salvage therapy
Hormonal agents
Tamoxifen:
Fulvestrant:
Aromatase inhibitors:
Examples:
• Letrozole
• Anastrozole
• Exemestane (irreversible)
Erlotinib:
HAND-FOOT
HAND-FOOT SKIN REACTION (HSFR)
SYNDROME (HFS)
Lesions Diffuse Sharply demarcated
Areas involved Palms and soles Heels, metatarsal heads, other areas
of friction
Characteristics Erythema and edema Erythmatous, edematous, tender
blisters that may evolve into painful
calluses
Pain Painful Painful
Associated Capecitabine Drugs inhibiting multiple tyrosine
with 5-FU kinases
Anti-TNF-α antibodies:
Indications:
• RA
• AS
• Plaque psoriasis (including psoriatic arthritis)
• Crohn’s disease
Contraindications:
1. Active infection / High risk of infection (including TB)
2. Malignancy / Pre-malignancy
3. Immune suppressed state (including HIV)
4. Hepatitis B
5. SLE
6. Multiple sclerosis
7. CHF
8. Pregnancy
9. Lactation
Immunosuppressants
Immunostimulants
1. Sedation
2. Constipation
3. Peripheral neuropathy (most serious)
4. Fatigue
5. Deep vein thrombosis
6. Hypothyroidism
7. Teratogenicity
• Phocomelia
• Mobius syndrome
Anti-cancer drugs causing peripheral neuropathy:
1. Vinca alkaloids
2. Taxanes
3. Platinum analogues
4. Thalidomide
5. Bortezomib
Indications of Interferon-α:
• Hairy cell leukaemia
• Follicular lymphomas
• Malignant melanoma
❑ ❑ ❑